N4P vs. HELD, DEMG, IDHC, PYC, OCTP, TRLS, NFX, GDR, FAB, and EVG
Should you be buying N4 Pharma stock or one of its competitors? The main competitors of N4 Pharma include Hellenic Dynamics (HELD), Deltex Medical Group (DEMG), Integrated Diagnostics (IDHC), Physiomics (PYC), Oxford Cannabinoid Technologies (OCTP), Trellus Health (TRLS), Nuformix (NFX), genedrive (GDR), Fusion Antibodies (FAB), and Evgen Pharma (EVG). These companies are all part of the "medical" sector.
Hellenic Dynamics (LON:HELD) and N4 Pharma (LON:N4P) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, community ranking, risk, institutional ownership, earnings, analyst recommendations and media sentiment.
N4 Pharma's return on equity of 0.00% beat Hellenic Dynamics' return on equity.
0.1% of Hellenic Dynamics shares are owned by institutional investors. 72.9% of Hellenic Dynamics shares are owned by company insiders. Comparatively, 22.3% of N4 Pharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
In the previous week, Hellenic Dynamics had 1 more articles in the media than N4 Pharma. MarketBeat recorded 1 mentions for Hellenic Dynamics and 0 mentions for N4 Pharma. N4 Pharma's average media sentiment score of 0.47 beat Hellenic Dynamics' score of 0.00 indicating that Hellenic Dynamics is being referred to more favorably in the media.
Hellenic Dynamics has higher earnings, but lower revenue than N4 Pharma.
N4 Pharma received 103 more outperform votes than Hellenic Dynamics when rated by MarketBeat users.
Summary
Hellenic Dynamics beats N4 Pharma on 6 of the 8 factors compared between the two stocks.
Get N4 Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for N4P and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding N4P and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
N4 Pharma Competitors List
Related Companies and Tools
